Robin L. Smith - Insider Trading & Ownership

Entity: Individual
Location: C/O Phase III Medical, Inc., 330 South Service Road, Suite 120, Melville, NY
Summary: The estimated net worth of Robin L. Smith is at least $247K dollars as of February 13, 2025. Robin L. Smith is the Director of Sorrento Therapeutics, Inc. and owns shares of Sorrento Therapeutics, Inc. (SRNE) stock worth about $189K. Robin L. Smith is the Director of Celularity Inc and owns shares of Celularity Inc (CELU) stock worth about $58.8K.
All Insider Reports: All Insider Reports

Ownership of Robin L. Smith

Symbol	Company	Relationship	Holdings Value	Report Period
SRNE	Sorrento Therapeutics, Inc.	Director	$189K	Sep 3, 2021
CELU, CELUW	Celularity Inc	Director	$58.8K	Jun 14, 2023
MTNB	Matinas BioPharma Holdings, Inc.	Director		Feb 13, 2025
WAVS, WAVSU	Western Acquisition Ventures Corp.	Director		Jan 11, 2022

Showing 1 to 4 of 4 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.